HIGHLIGHTS
SUMMARY
Lung cancer (LC) is one of the most common malignancies in the world today. Metastatic disease is already present at diagnosis in about 40% of patients with the most common sites being bone, liver, brain, and adrenal gland, while gastrointestinal sites are much more uncommon. No systematic review on the topic exists nor does a pooled analysis of PCLC patients. The aim of this systematic review is to investigate characteristics, management and overall survival of PCLC patients. Inclusion criteria were as follows: original articles (retrospective, prospective, randomised clinical trials), case series and report; articles . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.